Absorica and Dyspnea - a phase IV clinical study of FDA data

Summary:

Dyspnea is reported as a side effect among people who take Absorica (isotretinoin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Cellcept, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Dyspnea when taking Absorica. It is created by eHealthMe based on reports of 2,544 people who have side effects when taking Absorica from the FDA, and is updated regularly.

What is Absorica?

Absorica has active ingredients of isotretinoin. It is often used in acne. eHealthMe is studying from 2,556 Absorica users. Check the latest studies of Absorica.

What is Dyspnea?

Dyspnea (difficult or laboured breathing) is found to be associated with 3,715 drugs and 6,067 conditions by eHealthMe. Check the latest studies of Dyspnea.

On Jul, 23, 2026

2,544 people reported to have side effects when taking Absorica.
Among them, 13 people (0.51%) have Dyspnea.

Among these 13 people:

How long have people been on Absorica when they have Dyspnea? *

What is the gender of people who have Dyspnea when taking Absorica? *

female: 69.23 %
male: 30.77 %

What is the age of people who have Dyspnea when taking Absorica? *

What are other drugs people take besides Absorica? *

What are other side effects people have besides Dyspnea? *

Gastrointestinal Disorder (functional problems of gastrointestinal tract): 3 people, 23.08%
Pneumonia: 3 people, 23.08%
Gastric Ulcer (stomach ulcer): 3 people, 23.08%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 23.08%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 3 people, 23.08%
Constipation: 3 people, 23.08%
Cardiac Failure Congestive: 3 people, 23.08%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 23.08%
Nausea (feeling of having an urge to vomit): 3 people, 23.08%
Impaired Gastric Emptying: 3 people, 23.08%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 23.08%
Multiple Myeloma (cancer of the plasma cells): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Absorica and have Dyspnea?

- Check whether Dyspnea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Absorica:

Absorica (2,556 reports)

Dyspnea treatments and more:

Dyspnea (661,578 reports)

Browse all side effects of Absorica:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea:

Dyspnea (3,715 drugs)

Browse all the conditions that are associated with Dyspnea:

Dyspnea (6,067 conditions)

Related publications that referenced our studies

Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on isotretinoin (the active ingredients of Absorica) and Absorica (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.